Portfolio (Quarterly)
Guide ↗
Mirae Asset Global Investments Co., Ltd.
· CIK 0001569395| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 841 | FINV | FINVOLUTION GROUP | Financial Services | 4,356.0 | $21K | — | +39.0 | +0.9% | $4.79 | +1.3% |
| 842 | PACB | PACIFIC BIOSCIENCES CALIF IN | Healthcare | 15,752.0 | $21K | — | +1K | +7.4% | $1.32 | +4.5% |
| 843 | CTNM | CONTINEUM THERAPEUTICS INC | Healthcare | 1,588.0 | $21K | — | +466.0 | +41.5% | $13.06 | -11.7% |
| 844 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 5,663.0 | $20K | — | +404.0 | +7.7% | $3.58 | -24.6% |
| 845 | RERE | ATRENEW INC | Consumer Cyclical | 4,295.0 | $20K | — | +39.0 | +0.9% | $4.69 | -12.2% |
| 846 | ALT | ALTIMMUNE INC | Healthcare | 6,532.0 | $20K | — | +1K | +28.8% | $3.08 | -11.4% |
| 847 | IVVD | INVIVYD INC | Healthcare | 14,455.0 | $19K | — | +989.0 | +7.3% | $1.30 | -21.5% |
| 848 | CADL | CANDEL THERAPEUTICS INC | Healthcare | 3,821.0 | $19K | — | +1K | +43.2% | $4.90 | +73.5% |
| 849 | SAM | BOSTON BEER INC | Consumer Defensive | 80.0 | $18K | — | +9.0 | +12.7% | $230.40 | -26.2% |
| 850 | IMRX | IMMUNEERING CORP | Healthcare | 3,368.0 | $18K | — | +230.0 | +7.3% | $5.27 | -25.4% |
| 851 | SIGA | SIGA TECHNOLOGIES INC | Healthcare | 3,735.0 | $18K | — | +255.0 | +7.3% | $4.73 | -8.5% |
| 852 | KROS | KEROS THERAPEUTICS INC | Healthcare | 1,589.0 | $18K | — | +109.0 | +7.4% | $11.04 | -9.4% |
| 853 | NMRA | NEUMORA THERAPEUTICS INC. | Healthcare | 8,715.0 | $17K | — | +596.0 | +7.3% | $1.95 | -16.9% |
| 854 | PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | 2,654.0 | $17K | — | +205.0 | +8.4% | $6.39 | +7.2% |
| 855 | NGNE | NEUROGENE INC | Healthcare | 808.0 | $16K | — | +55.0 | +7.3% | $20.16 | +41.9% |
| 856 | LENZ | LENZ THERAPEUTICS INC | Healthcare | 1,632.0 | $15K | — | +112.0 | +7.4% | $9.15 | -26.6% |
| 857 | AVXL | ANAVEX LIFE SCIENCES CORP | Healthcare | 4,834.0 | $15K | — | +492.0 | +11.3% | $3.07 | -14.7% |
| 858 | FHTX | FOGHORN THERAPEUTICS INC | Healthcare | 3,056.0 | $15K | — | +308.0 | +11.2% | $4.78 | -22.4% |
| 859 | AUTL | AUTOLUS THERAPEUTICS LTD | Healthcare | 10,463.0 | $14K | — | +715.0 | +7.3% | $1.38 | +5.8% |
| 860 | ACIU | AC IMMUNE SA | Healthcare | 5,247.0 | $14K | — | +368.0 | +7.5% | $2.75 | -20.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
41.2%
Communication Services
12.3%
Consumer Cyclical
10.0%
Healthcare
8.1%
Financial Services
7.7%
Industrials
6.8%
Consumer Defensive
5.9%
Energy
3.6%
Utilities
2.1%
Basic Materials
1.2%